Cargando…

Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice

Metabolic homeostasis is critical for all biological processes in the brain. The metabolites are considered the best indicators of cell states and their rapid fluxes are extremely sensitive to cellular changes. While there are a few studies on the metabolomics of Parkinson’s disease, it lacks longit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xi, Xie, Chengsong, Sun, Lixin, Ding, Jinhui, Cai, Huaibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552665/ https://www.ncbi.nlm.nih.gov/pubmed/26317866 http://dx.doi.org/10.1371/journal.pone.0136612

Ejemplares similares

Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
por: Gu, Xing-Long, et al.
Publicado: (2010)

No apparent transmission of transgenic α–synuclein into nigrostriatal dopaminergic neurons in multiple mouse models
por: Sastry, Namratha, et al.
Publicado: (2015)

Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging
por: Chen, Xi, et al.
Publicado: (2020)

Correction to: Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging
por: Chen, Xi, et al.
Publicado: (2020)

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson’s disease
por: Cai, Huaibin, et al.
Publicado: (2014)

Genetic ablation of dynactin p150(Glued) in postnatal neurons causes preferential degeneration of spinal motor neurons in aged mice
por: Yu, Jia, et al.
Publicado: (2018)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Developmental Changes in Dendritic Spine Morphology in the Striatum and Their Alteration in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
por: Parajuli, Laxmi Kumar, et al.
Publicado: (2020)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice
por: Argyrofthalmidou, Maria, et al.
Publicado: (2021)

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian
por: Mo, Mingshu, et al.
Publicado: (2016)

Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice
por: Naudet, Nicolas, et al.
Publicado: (2017)

Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

Environmental Enrichment Attenuates Oxidative Stress and Alters Detoxifying Enzymes in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
por: Seo, Jung Hwa, et al.
Publicado: (2020)

Nigrostriatal dynein changes in A53T alpha-synuclein transgenic mice
por: Liu, Yan, et al.
Publicado: (2014)

Rotenone aggravates PD-like pathology in A53T mutant human α-synuclein transgenic mice in an age-dependent manner
por: Chen, An-Di, et al.
Publicado: (2022)

Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l
por: Yan, Jianguo, et al.
Publicado: (2017)

Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies
por: Price, Diana L., et al.
Publicado: (2016)

Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson’s Disease
por: Tian, Ye, et al.
Publicado: (2021)

Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
por: Huang, Yue, et al.
Publicado: (2012)

Olfactory Dysfunction and Neurotransmitter Disturbance in Olfactory Bulb of Transgenic Mice Expressing Human A53T Mutant α-Synuclein
por: Zhang, Sufang, et al.
Publicado: (2015)

Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein
por: Peters, Samuel T., et al.
Publicado: (2020)

Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s disease
por: Yan, Yaping, et al.
Publicado: (2021)

Longitudinal Analyses of Cerebrospinal Fluid α-Synuclein in Prodromal and Early Parkinson’s Disease
por: Mollenhauer, Brit, et al.
Publicado: (2019)

Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic Mice
por: Lee, He-Jin, et al.
Publicado: (2011)

Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice
por: Spinelli, Kateri J., et al.
Publicado: (2015)

Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice
por: Di Martino, Rossana, et al.
Publicado: (2021)

Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease
por: Wills, Jonathan, et al.
Publicado: (2011)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson’s disease A53T mouse model
por: Flores-Cuadrado, Alicia, et al.
Publicado: (2019)

Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice
por: Pavia-Collado, Rubén, et al.
Publicado: (2021)

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
por: Foulds, Penelope G., et al.
Publicado: (2013)

Redistribution of DAT/α-Synuclein Complexes Visualized by “In Situ” Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease
por: Bellucci, Arianna, et al.
Publicado: (2011)

Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
por: Dhillon, Jess-Karan S., et al.
Publicado: (2019)

Network dysfunction in α‐synuclein transgenic mice and human Lewy body dementia
por: Morris, Meaghan, et al.
Publicado: (2015)

Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
por: Bido, Simone, et al.
Publicado: (2017)

CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic mice
por: Caló, Laura, et al.
Publicado: (2021)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

Effects of α-Synuclein Overexpression in Transgenic Caenorhabditis elegans Strains
por: Bodhicharla, Rakesh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q45im9i7ojknf9uqsrc535d3dp